 |
answer text |
<p>The National Institute for Health Research (NIHR) Clinical Research Network is
currently setting up a study that will aim to image amyloid deposition in systemic
amyloidosis using hybrid positron emission tomography/magnetic resonance imaging,
with the future potential to diagnose and monitor treatment response in this condition.</p><p>
</p><p> </p><p> </p><p>The NIHR Health Technology Assessment programme is funding
a £1.9 million trial assessing the benefit of antibiotic prophylaxis and its effect
on healthcare associated infections in myeloma patients.</p><p> </p><p> </p><p> </p><p>The
NIHR is hosting a wide range of commercial and non-commercial myeloma treatment trials
and studies through its Clinical Research Network, biomedical research centres, clinical
research facilities, and through experimental cancer medicine centres funded jointly
with Cancer Research UK.</p><p> </p>
|
 |
